Title
Abbot Laboratories vs. Agrava
Case
G.R. No. L-4234
Decision Date
May 21, 1952
Abbot Laboratories appealed denial of priority rights for "Tridione" patent, citing Section 76 of Philippine Patent Law. Court upheld Director of Patents' decision, ruling reciprocity must exist at application time, affirming February 29, 1948, deadline under executive agreement.

Case Digest (G.R. No. L-4234)

Facts:

Abbot Laboratories, a Philippine corporation, appealed from the decision of the Director of Patents denying Patent Application Serial No. 77 for the medical preparation "Tridione" and refusing priority under Section 76 of Rep. Act No. 165. The application, filed in June 1948 and claiming priority from three United States applications (filed July 18, 1941; November 26, 1945; and October 11, 1947), was held by the Director to be filed too late because, he found, reciprocal priority rights in the United States had expired by February 1948; Abbot contended the statutory extension ran until July 1, 1948. The appeal sought judicial review under Chapter XIII of Rep. Act No. 165.

Issues:

  • Did the Director of Patents correctly deny priority under Section 76 because reciprocal priority rights in the United States expired by February 1948?
  • Is the invention unpatentable under Section 9 of Rep. Act No. 165 by reason of prior publication in the August 1944 issue of the Journal of the American Chemical Society?

Ruling:

The Court affirmed the decision of the Director of Patents denying the request for priority. The Court held that the diplomatic notes exchanged between the United States Secretary of State and the Philippine Ambassador did not amend Section 76 but properly interpreted it to mean that Americans could claim priority only for applications filed while Filipinos enjoyed reciprocal rights in the United States, which had lapsed by February 1948; therefore Abbot's June 1948 claim of priority failed. The Court declined to decide the contention under Section 9 and also deemed unnecessary the procedural question on petitioner's capacity to appeal; costs were imposed on petitioner.

Ratio:

The Court construed Section 76 as a reciprocity provision that grants foreign priority only insofar as citizens of the Philippines enjoy substantially reciprocal privileges in the foreign country at the relevant time. The exchanged diplomatic notes merely applied that reciprocity principle to the United States context—referring to the Boykin Act and the U.S. expiration date of February 29, 1948—and did not abridge the statutory July 1, 1948 terminal date; they established that no reciprocity existed for applications filed in June 1948, justifying the Director's denial.

Doctrine:

  • Section 76 of Rep. Act No. 165 is a reciprocity measure granting foreign priority rights only while corresponding privileges are afforded to Filipinos in the foreign country.
  • (Get Pro to unlock 3 more doctrines)

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.